It took a while to get here, but the Fed finally cut interest rates last week. U.S. and European share markets reacted positively to the FOMC policy directive for a 50 bps Fed Funds rate cut. That was...
For Immediate ReleaseChicago, IL – September 24, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...
Wave Life Sciences has received recent Wall Street price targets forecasting big upside. The company has a potentially "industry-leading" treatment.
In a groundbreaking study, Chinese scientists have revealed that classical music could be a powerful tool in the fight against treatment-resistant depression, a condition that affects nearly 50% of patients...
These outstanding growth stocks are worth buying on the dip.
Now may be a good time for dividend investors to consider loading up on this stock.
There are very good reasons that stocks generally gain in value after a company receives %OrphanDrug designation (ODD). A study published in Orphanet Journal of Rare Diseases showed that the average stock...
If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. Positive Opinion...
One of these high-yield pharma stocks stands out as a better buy right now.
These two high-yield dividend stocks are attractive buys right now.